MAPT and Alzheimer disease: Accumulating evidence shows that the metal ions were dysregulated in the vulnerable brain regions of AD patients, which was highly associated with Aβ deposition, tau hyperphosphorylation, neuronal loss, as well as neuroinflammation [57].